Zasocitinib for treating moderate to severe plaque psoriasis [TSID12318]

  • Awaiting development
  • GID-TA11926
  • Expected publication date: TBC

33943-Zasocitinib-for-Plaque-Psoriasis-V1.0-OCT2025-NON-CONF.pdf